New oral drug treatment for some advanced breast cancer

/ /by

The FDA has approved a new oral drug for the treatment of HR-positive, HER2-negative advanced breast cancer. A companion blood test was also approved to help doctors identify patients who would benefit most from this new treatment.

New oral drug treatment for some advanced breast cancer